Where can I verify the source and access all details for “Intranasal Antiviral Vaccine Platform Clinical Trial Manufacturing”?

This Taiyo project page references BioPharma APAC along with the original URL (https://www.biopharmaapac.com/news/48/8150/matica-bio-partners-with-vaxdome-to-advance-novel-intranasal-antiviral-vaccine-platform-into-clinical-trials.html). Taiyo standardizes official data into a consistent, searchable project profile.

Intranasal Antiviral Vaccine Platform Clinical Trial Manufacturing

Q: What is the latest status of the project “Intranasal Antiviral Vaccine Platform Clinical Trial Manufacturing”?

The status recorded for “Intranasal Antiviral Vaccine Platform Clinical Trial Manufacturing” is under construction.

Sector: Manufacturing (Industrial) • Location: College Station, Texas, United States

Project

Under Construction

Matica Bio is partnering with VaxDome to develop and manufacture VaxDome's novel antigen-agnostic antiviral-vaccine hybrid candidates for clinical trials. The project involves process development, analytical development, and production of clinical materials at Matica Bio's facility in College Station, Texas, to advance the vaccine platform into first-in-human studies.

Status: Under Construction
Sector: Manufacturing (Industrial)
Location: College Station, Texas, United States of America
Updated: 22 Jul 2026
Source: BioPharma APAC

ConstructChat

Ask ConstructChat about Intranasal Antiviral Vaccine Platform Clinical Trial Manufacturing

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information

3 Q

The project “Intranasal Antiviral Vaccine Platform Clinical Trial Manufacturing” is an infrastructure initiative in the Manufacturing (Industrial) sector, located in College Station, Texas, United States. Taiyo aggregates data on it from BioPharma APAC.

Participants

Not available for this record.

Status

Original status	under construction
Taiyo status	Under Construction
Taiyo last update	2026-07-22

Contact

Not available for this record.

Description

Description	Matica Bio is partnering with VaxDome to develop and manufacture VaxDome's novel antigen-agnostic antiviral-vaccine hybrid candidates for clinical trials. The project involves process development, analytical development, and production of clinical materials at Matica Bio's facility in College Station, Texas, to advance the vaccine platform into first-in-human studies.
Original sector	Pharma & Biopharma Manufacturing

Location

Country	United States of America (USA)
State	Texas
City	College Station

Source

Source	BioPharma APAC
URL

More Details

Record type	Project
Sector	Manufacturing (Industrial)
Article published date	2026-07-11

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

Every detail on this project
News and media coverage
Technical research

View all details

Free account · no card · lands you back on this project

Intranasal Antiviral Vaccine Platform Clinical Trial Manufacturing

Ask ConstructChat about Intranasal Antiviral Vaccine Platform Clinical Trial Manufacturing

Project Information FAQ

Project Information

Research

View all details

More Manufacturing (Industrial) projects in United States